SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $5,396,779,685 |
| Positions | 129 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| EDGEWISE THERAPEUTICS INC | EWTX | COM | $630,516,330 | 15,518,492 |
| ENLIVEN THERAPEUTICS INC | ELVN | COM | $343,914,074 | 6,776,632 |
| ELI LILLY & CO | LLY | COM | $309,332,997 | 257,900 |
| MBX BIOSCIENCES INC | MBX | COM | $189,266,227 | 3,428,736 |
| SINOVAC BIOTECH LTD | Unresolved | SHS | $184,466,170 | 2,718,735 |
| ASTRAZENECA PLC | AZN | ORD | $171,079,502 | 915,700 |
| STRUCTURE THERAPEUTICS INC | GPCR | SPONSORED ADS | $118,578,498 | 2,209,400 |
| SIONNA THERAPEUTICS INC | SION | COM | $112,433,029 | 2,555,877 |
| CORVUS PHARMACEUTICALS INC | CRVS | COM | $107,045,190 | 7,165,006 |
| ARRIVENT BIOPHARMA INC | AVBP | COM | $105,169,375 | 3,027,328 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.